What is Kiniksa Pharmaceuticals International Days Inventory?
Kiniksa Pharmaceuticals InternationalKNSA -1.57%54 Days Inventory is 60.61 as of Mar. 2026, which is 38% below its 10-year median of 98.21. GuruFocus rates KNSA with a GF Score™ of 54/100 and a GF Value™ of $48.15 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 917 Drug Manufacturers companies, Kiniksa Pharmaceuticals International ranks better than 93.78% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Kiniksa Pharmaceuticals International's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.51.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kiniksa Pharmaceuticals International's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.30.
Kiniksa Pharmaceuticals International (NAS:KNSA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Kiniksa Pharmaceuticals International's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kiniksa Pharmaceuticals International's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Kiniksa Pharmaceuticals International Days Inventory Related Terms
Kiniksa Pharmaceuticals International Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kiniksa Pharmaceuticals International Days Inventory Chart
KNSA vs INDV, AMRX, RGC: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kiniksa Pharmaceuticals International's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kiniksa Pharmaceuticals International Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kiniksa Pharmaceuticals International's Days Inventory distribution charts can be found below:
* The bar in red indicates where Kiniksa Pharmaceuticals International's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kiniksa Pharmaceuticals International (KNSA) has a Days Inventory of 60.61 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kiniksa Pharmaceuticals International and its competitors. This is 38% below median its historical median of 98.21. Over the past decade, Kiniksa Pharmaceuticals International's Days Inventory has ranged from 48.27 to 135.02. According to the industry distribution chart, Kiniksa Pharmaceuticals International ranks #57 out of 917 companies in the Drug Manufacturers industry, placing it in the top 6.2%.
Is Kiniksa Pharmaceuticals International's Days Inventory too high?
Kiniksa Pharmaceuticals International's current Days Inventory of 60.61 is 38% below median its 10-year median of 98.21. Over the past 10 years, this metric has ranged from a low of 48.27 to a high of 135.02. The Drug Manufacturers industry median Days Inventory is 164.48. Kiniksa Pharmaceuticals International's value of 60.61 is 63.2% below this industry median. Based on the distribution chart, Kiniksa Pharmaceuticals International ranks #57 out of 917 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kiniksa Pharmaceuticals International has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kiniksa Pharmaceuticals International's Days Inventory compare to INDV and AMRX?
According to the Drug Manufacturers industry distribution chart, Kiniksa Pharmaceuticals International ranks #57 out of 917 companies for Days Inventory. This places Kiniksa Pharmaceuticals International in the top 6% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Kiniksa Pharmaceuticals International's value of 60.61 is 63.2% below this benchmark. Historically, Kiniksa Pharmaceuticals International's own Days Inventory has ranged from 48.27 to 135.02 over the past decade. While the company's 10-year median is 98.21 vs. the industry median of 164.48, Kiniksa Pharmaceuticals International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 917 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kiniksa Pharmaceuticals International's current Days Inventory of 60.61 is 63.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kiniksa Pharmaceuticals International and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kiniksa Pharmaceuticals International's current Days Inventory is 60.61, which is 38% below median its own 10-year median of 98.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kiniksa Pharmaceuticals International stock overvalued right now?
Based on GuruFocus' analysis, Kiniksa Pharmaceuticals International (KNSA) is currently considered Significantly Overvalued. The stock's GF Value™ is $48.15, compared to a current price of $62.88 — trading 30.6% above its estimated fair value. The current Days Inventory is 60.61, which is 38% below median its 10-year median of 98.21 and 63.2% below the Drug Manufacturers industry median of 164.48. Kiniksa Pharmaceuticals International's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Kiniksa Pharmaceuticals International (KNSA), the current Days Inventory is 60.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kiniksa Pharmaceuticals International (KNSA) Overvalued in 2026?
Based on GuruFocus' analysis, Kiniksa Pharmaceuticals International stock appears to be overvalued.
The current stock price of $62.88 is trading 30.6% above its estimated GF Value™ of $48.15.
GuruFocus considers Kiniksa Pharmaceuticals International to be Significantly Overvalued.
Key valuation signals for KNSA:
Days Inventory: 60.61 (38% below median its 10-year median of 98.21)
GF Value™: $48.15 vs. price of $62.88 (30.6% above fair value)
Industry Position: 63.2% below the Drug Manufacturers median (#57 of 917)
No single metric tells the full story. See the KNSA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kiniksa Pharmaceuticals International Business Description
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
54GF Score
Get the complete analysis for KNSA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KNSA has been successfully added to your 
